Stephen W. Kidder’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $249K | Hold |
4,100
| – | – | 0.07% | 69 |
|
|
2025
Q4 | $221K | Buy |
+4,100
| New | +$197K | 0.06% | 70 |
|
|
2025
Q3 | – | Sell |
-4,750
| Closed | -$220K | – | 75 |
|
|
2025
Q2 | $220K | Buy |
4,750
+150
| +3% | +$7.36K | 0.07% | 73 |
|
|
2025
Q1 | $281K | Hold |
4,600
| – | – | 0.09% | 61 |
|
|
2024
Q4 | $260K | Hold |
4,600
| – | – | 0.08% | 60 |
|
|
2024
Q3 | $238K | Sell |
4,600
-550
| -11% | -$25.8K | 0.07% | 66 |
|
|
2024
Q2 | $214K | Sell |
5,150
-50
| -1% | -$2.24K | 0.07% | 68 |
|
|
2024
Q1 | $282K | Sell |
5,200
-141
| -3% | -$7.18K | 0.09% | 60 |
|
|
2023
Q4 | $274K | Sell |
5,341
-140
| -3% | -$7.35K | 0.09% | 65 |
|
|
2023
Q3 | $318K | Hold |
5,481
| – | – | 0.11% | 62 |
|
|
2023
Q2 | $351K | Hold |
5,481
| – | – | 0.11% | 62 |
|
|
2023
Q1 | $380K | Sell |
5,481
-100
| -2% | -$7.05K | 0.13% | 60 |
|
|
2022
Q4 | $402K | Buy |
+5,581
| New | +$421K | 0.15% | 60 |
|
|
2019
Q1 | – | Sell |
-4,850
| Closed | -$252K | – | 75 |
|
|
2018
Q4 | $252K | Hold |
4,850
| – | – | 0.11% | 69 |
|
|
2018
Q3 | $301K | Sell |
4,850
-500
| -9% | -$29.7K | 0.11% | 78 |
|
|
2018
Q2 | $297K | Sell |
5,350
-150
| -3% | -$8.1K | 0.11% | 79 |
|
|
2018
Q1 | $347K | Sell |
5,500
-1,100
| -17% | -$70.8K | 0.13% | 72 |
|
|
2017
Q4 | $405K | Buy |
6,600
+1,600
| +32% | +$100K | 0.15% | 72 |
|
|
2017
Q3 | $318K | Sell |
5,000
-200
| -4% | -$11.7K | 0.12% | 78 |
|
|
2017
Q2 | $290K | Hold |
5,200
| – | – | 0.11% | 80 |
|
|
2017
Q1 | $283K | Sell |
5,200
-500
| -9% | -$27.4K | 0.11% | 83 |
|
|
2016
Q4 | $334K | Hold |
5,700
| – | – | 0.14% | 79 |
|
|
2016
Q3 | $307K | Sell |
5,700
-2,500
| -30% | -$161K | 0.12% | 80 |
|
|
2016
Q2 | $603K | Sell |
8,200
-200
| -2% | -$14.1K | 0.24% | 64 |
|
|
2016
Q1 | $536K | Hold |
8,400
| – | – | 0.22% | 64 |
|
|
2015
Q4 | $578K | Hold |
8,400
| – | – | 0.25% | 63 |
|
|
2015
Q3 | $497K | Sell |
8,400
-100
| -1% | -$6.34K | 0.25% | 61 |
|
|
2015
Q2 | $565K | Sell |
8,500
-1,500
| -15% | -$98.9K | 0.26% | 60 |
|
|
2015
Q1 | $644K | Sell |
10,000
-500
| -5% | -$31.3K | 0.28% | 61 |
|
|
2014
Q4 | $620K | Hold |
10,500
| – | – | 0.27% | 65 |
|
|
2014
Q3 | $537K | Buy |
+10,500
| New | +$524K | 0.24% | 64 |
|
Other funds holding BMY
VCM
VPM
Stephen W. Kidder's BMY Position: Q1 2026 in Review
Stephen W. Kidder held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 4,100 shares worth $249K. The position accounts for 0.07% of the portfolio, ranked #69.
Stephen W. Kidder first reported a position in BMY in Q3 2014 and has held it in 31 quarters since. The position peaked at $644K in Q1 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Stephen W. Kidder held 4,100 shares of Bristol-Myers Squibb worth $249K as of Q1 2026.
- Stephen W. Kidder left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.07% of Stephen W. Kidder's portfolio in Q1 2026, its #69 holding.
- Stephen W. Kidder first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 31 quarters since.
- Stephen W. Kidder's Bristol-Myers Squibb position peaked at $644K in Q1 2015.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Stephen W. Kidder's 13F filing for Q1 2026, filed 11 May 2026.